Spotlight on the Fastest Growing Segments in the Life Sciences
ARLINGTON, Va., Sept. 18, 2017 /PRNewswire/ -- BioInformatics LLC has released four reports for the life science tools industry that focus on the fastest growing segments of the market. These include the markets for CRISPR, single cell analysis, Next Generation Sequencing data analysis, and the growing demand for analytical instruments in China.
"The market for life science instruments and consumables has been growing modestly over the last few years," observed Craig Overpeck, CEO of BioInformatics. "That makes it all the more important for our clients to identify and focus on the market's hotspots which are both technology-based and regional."
Nowhere is this growth more apparent than the market for CRISPR/Cas9 products and services, which BioInformatics projects to grow at 45% over the next five years and reaching $3.8 billion by 2021. Recent concerns raised over the frequency of off-target effects using the technique are not deterring scientists from using it, and the rate of adoption is only increasing – to the benefit of companies like Agilent, Horizon Discovery and MilliporeSigma.
The importance of single cell analysis, especially in the well-funded cancer research area, is fueling demand for microfluidic-based cell isolation and increasingly robust and reliable instrumentation from market leaders such as 10X Genomics, BD Biosciences, Bio-Rad Laboratories and others. Single cell analysis, and many other applications, utilize Next Generation Sequencing (NGS) but the huge troves of data being generated are becoming a significant workflow bottleneck. The need for new informatics tools for NGS data analysis and storage is attracting hundreds of companies to this fragmented market, where no true winner has yet emerged.
Finally, as international companies have outsourced research and manufacturing to China, the demand for a wide variety of analytical instruments has grown to become a $6 billion market, growing by 5.8% over the next five years.
Market reports from BioInformatics and SDI are unique in their combination of reliable market forecasts and actionable Voice of Customer survey data. The topics addressed include brand health, brand awareness, usage, market share, experimental workflow, customer satisfaction, switching behavior, spending plans, and more. Complimentary Executive Summaries can be downloaded from BioInformatics' catalog (https://www.gene2drug.com/reports/) and incentives for the bundle of reports are available for clients committed before the end of Q3 2017.
ABOUT BIOINFORMATICS LLC
BioInformatics LLC and its SDi division form the premier research and advisory firm serving senior executives at companies making the tools of science. By leveraging our expert network of tens of thousands of scientists, the company has supported more than 500 companies in creating insights that lead to better business decisions. Custom research offerings include assessing the size and attractiveness of scientific markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
For more information contact:
Devin Holland
BioInformatics LLC
2111 Wilson Boulevard
Suite 250
Arlington, VA 22201
Phone: 703.778.3080 x-19
[email protected]
www.gene2drug.com
SOURCE BioInformatics LLC
Share this article